Pathogenesis of spinally mediated hyperalgesia in diabetes.
about
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathySelective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathyDifferent roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.Effects of exogenous galanin on neuropathic pain state and change of galanin and its receptors in DRG and SDH after sciatic nerve-pinch injury in rat.Inflammation in the pathogenesis of microvascular complications in diabetes.Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Inhibition of IκB kinase (IKK) protects against peripheral nerve dysfunction of experimental diabetes.Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathyDiabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters.COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice.Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia.Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic ratsDiabetic painful and insensate neuropathy: pathogenesis and potential treatments.The beneficial effects of C-Peptide on diabetic polyneuropathy.Mechanism of diabetic neuropathy: Where are we now and where to go?Allopregnanolone suppresses diabetes-induced neuropathic pain and motor deficit through inhibition of GABAA receptor down-regulation in the spinal cord of diabetic rats.The association of vitamin D with inflammatory cytokines in diabetic peripheral neuropathy.Proanthocyanidin B2 attenuates high-glucose-induced neurotoxicity of dorsal root ganglion neurons through the PI3K/Akt signaling pathway
P2860
Q28580927-B8CA575E-8CCC-4465-87DF-7E111D86DF0DQ30836715-06A8DFE7-2B0E-416E-9F58-CA05BBB91F93Q34086993-573E6F7E-BF0D-4CBD-A0BE-598F6EB8006AQ34280108-A06198F1-F88D-4174-8BD5-28C509AD3C6AQ34319638-AF782451-C80D-47DC-808F-512038288E83Q34603008-DE6AABB6-323C-4EE4-8005-4FA0BA4E9F31Q35122783-7A2EDCF3-E597-449C-A043-2277C0DB6EEEQ35191507-C785FF8F-369C-4467-B7E8-0F5699CA78E2Q35784340-D2D1F3DC-63AF-44FF-82FA-34F08BE6BAF8Q36293649-13FE9587-6728-4D82-904E-BB1597EAA4F2Q36684873-5433376B-D4C9-4671-9B42-AF777CC48443Q36841926-114101E6-3CB1-412B-9873-99130E3DA344Q36995022-4B567BB7-E908-48EA-8AC6-BA666C551DE6Q37073724-6AC5A9A3-6257-4589-888F-F4A868197E94Q37093006-0221D0CA-F0C0-45F9-9778-EFFE4A4EC25AQ37343591-11E24064-EACF-4819-8ADE-1C866D5C2E29Q37605348-75D76E92-BD07-4325-8ABD-E86554AA7B4AQ37663812-A530295C-EA7F-48B6-97CC-B276009C4458Q38213041-0B15CD52-7E03-43DF-BA78-98C3EDD20F8EQ41132735-CE054DBA-E31B-457C-B440-26FE1490D332Q42389895-6E251280-42FF-42FD-B3B7-DA735BC26B5BQ58776004-1E449CD0-ED6A-4505-BC08-D8CAD5146DD5
P2860
Pathogenesis of spinally mediated hyperalgesia in diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@en
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@nl
type
label
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@en
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@nl
prefLabel
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@en
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@nl
P2093
P356
P1433
P1476
Pathogenesis of spinally mediated hyperalgesia in diabetes.
@en
P2093
Khara M Ramos
Nigel A Calcutt
P304
P356
10.2337/DB06-1269
P407
P577
2007-02-07T00:00:00Z